Picture of Indivior logo

INDV Indivior Income Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual income statement for Indivior, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
R2022
December 31st
R2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue6477919011,0931,188
Cost of Revenue
Gross Profit5556647569331,013
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses8105879821,2491,156
Operating Profit-163204-81-15632
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-173190-89-14914
Provision for Income Taxes
Net Income After Taxes-148205-45-1293
Net Income Before Extraordinary Items
Net Income-148205-45-1293
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-148205-43-1292
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.9551.61.11.521.31